Kestra Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Buy
4,518
+134
+3% +$7.62K ﹤0.01% 3252
2026
Q2
$348K Buy
4,384
+12
+0.3% +$903 ﹤0.01% 2629
2026
Q1
$328K Sell
4,372
-79
-2% -$6.24K ﹤0.01% 2551
2025
Q4
$352K Sell
4,451
-521
-10% -$39.2K ﹤0.01% 2401
2025
Q3
$325K Buy
+4,972
New +$243K ﹤0.01% 2377
2024
Q3
– Sell
-5,491
Closed -$236K – 2648
2024
Q2
$236K Sell
5,491
-59
-1% -$2.42K ﹤0.01% 2287
2024
Q1
$241K Buy
5,550
+510
+10% +$24.3K ﹤0.01% 2154
2023
Q4
$255K Buy
5,040
+62
+1% +$2.97K ﹤0.01% 1951
2023
Q3
$226K Sell
4,978
-220
-4% -$9.08K ﹤0.01% 1859
2023
Q2
$213K Buy
+5,198
New +$200K ﹤0.01% 1867
2023
Q1
– Sell
-22,413
Closed -$847K – 2195
2022
Q4
$847K Sell
22,413
-512
-2% -$21.5K 0.01% 1139
2022
Q3
$1.01M Buy
22,925
+94
+0.4% +$3.96K 0.01% 969
2022
Q2
$845K Sell
22,831
-786
-3% -$29.6K 0.01% 1053
2022
Q1
$875K Buy
23,617
+3,936
+20% +$129K 0.01% 1019
2021
Q4
$599K Sell
19,681
-8,243
-30% -$259K 0.01% 1223
2021
Q3
$937K Buy
27,924
+5,078
+22% +$191K 0.01% 1055
2021
Q2
$911K Sell
22,846
-104
-0.5% -$4.07K 0.01% 990
2021
Q1
$1.03M Buy
+22,950
New +$1.28M 0.01% 848

Other funds holding IONS

Kestra Advisory Services's IONS Position: Q3 2026 in Review

Kestra Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 3.1% in Q3 2026, buying an estimated $7.62K and bringing the position to 4,518 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

Kestra Advisory Services first reported a position in IONS in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.03M in Q1 2021. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Kestra Advisory Services held 4,518 shares of Ionis Pharmaceuticals worth $202K as of Q3 2026.
  • Kestra Advisory Services bought 134 Ionis Pharmaceuticals shares in Q3 2026, an estimated $7.62K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3252 holding.
  • Kestra Advisory Services first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Kestra Advisory Services's Ionis Pharmaceuticals position peaked at $1.03M in Q1 2021.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.